Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Mycobacterium abscessus complex

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The emergence of chronic MABC infections among immunocompromised populations and their inherent and acquired resistance to… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2019
2019
Pulmonary disease due to infection with Mycobacterium abscessus complex (MABC) is notoriously difficult to treat, in large part… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Review
2018
Review
2018
&NA; Of the nontuberculous mycobacteria (NTMs) causing lung disease, members of the Mycobacterium abscessus complex (MABc… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
2018
2018
Nontuberculous mycobacteria (NTM) are an important emerging threat to cystic fibrosis (CF) patients. In North America, where the… Expand
2017
2017
OBJECTIVES The differentiation between Mycobacterium abscessus subspecies abscessus (M. abscessus) and Mycobacterium abscessus… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2017
2017
Macrolides, especially clarithromycin (CLA), remain the cornerstone of therapy for Mycobacterium abscessus complex infections… Expand
  • table 1
  • table 2
2016
2016
Infections in 6 states were linked to persons traveling to undergo cosmetic surgical procedures. 
  • figure 1
  • table 1
  • figure 2
  • table 2
2015
2015
Early signs of pulmonary disease with Mycobacterium abscessus complex (MABSC) can be missed in patients with cystic fibrosis (CF… Expand
Highly Cited
2013
Highly Cited
2013
BACKGROUND Clinical observations suggest that Mycobacterium avium complex (MAC) and Mycobacterium abscessus complex (MABSC) may… Expand
2012
2012
Cystic fibrosis (CF) patients are at particularly high risk of developing lung disease caused by Mycobacterium abscessus complex… Expand